|
1
|
Gorsky M, Epstein JB, Oakley C, Le ND, Hay
J and Stevenson-Moore P: Carcinoma of the tongue: A case series
analysis of clinical presentation, risk factors, staging, and
outcome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
98:546–552. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Willén R, Nathanson A, Moberger G and
Anneroth G: Squamous cell carcinoma of the gingiva. Histological
classification and grading of malignancy. Acta Otolaryngol.
79:146–154. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sasaki M, Aoki T, Karakida K, Otsuru M,
Takahashi M, Akamatsu T, Sakamoto H and Ota Y: Postoperative
follow-up strategy in patients with oral squamous cell carcinoma. J
Oral Maxillofac Surg. 69:e105–e111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pantel K and Brakenhoff RH: Dissecting the
metastatic cascade. Nat Rev Cancer. 4:448–456. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Burchill SA, Bradbury MF, Pittman K,
Southgate J, Smith B and Selby P: Detection of epithelial cancer
cells in peripheral blood by reverse transcriptase-polymerase chain
reaction. Br J Cancer. 71:278–281. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Noguchi T, Shibata T, Fumoto S, Sato T,
Uchida Y, Daa T, Yokoyama S, Gabbert HE, Mueller W and Takeno S:
Detection of disseminated cancer cells in rib marrow of patients
with esophageal cancer. Oncol Rep. 10:623–627. 2003.PubMed/NCBI
|
|
7
|
Davelaar EM, van de Lande J, von
Mensdorff-Pouilly S, Blankenstein MA, Verheijen RH and Kenemans P:
A combination of serum tumor markers identifies high-risk patients
with early-stage squamous cervical cancer. Tumour Biol. 29:9–17.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Benoy IH, Elst H, Philips M, Wuyts H, Van
Dam P, Scharpé S, Van Marck E, Vermeulen PB and Dirix LY: Real-time
RT-PCR detection of disseminated tumour cells in bone marrow has
superior prognostic significance in comparison with circulating
tumour cells in patients with breast cancer. Br J Cancer.
94:672–680. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Soeth E, Grigoleit U, Moellmann B, Röder
C, Schniewind B, Kremer B, Kalthoff H and Vogel I: Detection of
tumor cell dissemination in pancreatic ductal carcinoma patients by
CK 20 RT-PCR indicates poor survival. J Cancer Res Clin Oncol.
131:669–676. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Partridge M, Brakenhoff R, Phillips E, Ali
K, Francis R, Hooper R, Lavery K, Brown A and Langdon J: Detection
of rare disseminated tumor cells identifies head and neck cancer
patients at risk of treatment failure. Clin Cancer Res.
9:5287–5294. 2003.PubMed/NCBI
|
|
11
|
Gath HJ, Heissler E, Hell B, Bier J,
Riethmüller G and Pantel K: Immunocytologic detection of isolated
tumor cells in bone marrow of patients with squamous cell
carcinomas of thehead and neck region. Int J Oral Maxillofac Surg.
24:351–355. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iinuma H, Okinaga K, Egami H, Mimori K,
Hayashi N, Nishida K, Adachi M, Mori M and Sasako M: Usefulness and
clinical significance of quantitative real-time RT-PCR to detect
isolated tumor cells in the peripheral blood and tumor drainage
blood of patients with colorectal cancer. Int J Oncol. 28:297–306.
2006.PubMed/NCBI
|
|
13
|
Gradilone A, Gazzaniga P, Silvestri I,
Gandini O, Trasatti L, Lauro S, Frati L and Aglianò A: Detection of
CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma
patients: Correlation with clinical stage of disease. Oncol Rep.
10:217–222. 2003.PubMed/NCBI
|
|
14
|
Lin JC, Chen KY, Wang WY, Jan JS and Wei
YH: PCR detection of circulating tumor cells in nasopharyngeal
carcinoma patients with distant metastasis: Effect of enzyme and
sampling. Head Neck. 24:591–596. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chaubal S, Wollenberg B, Kastenbauer E and
Zeidler R: Ep-CAM-a marker for the detection of disseminated tumor
cells in patients suffering from SCCHN. Anticancer Res.
19:2237–2242. 1999.PubMed/NCBI
|
|
16
|
Brakenhoff RH, Stroomer JG, ten Brink C,
de Bree R, Weima SM, Snow GB and van Dongen GA: Sensitive detection
of squamous cells in bone marrow and blood of head and neck cancer
patients by E48 reverse transcriptase-polymerase chain reaction.
Clin Cancer Res. 5:725–732. 1999.PubMed/NCBI
|
|
17
|
Xu XC, Lee JS, Lippman SM, Ro JY, Hong WK
and Lotan R: Increased expression of cytokeratins CK8 and CK19 is
associated with head and neck carcinogenesis. Cancer Epidemiol
Biomarkers Prev. 4:871–876. 1995.PubMed/NCBI
|
|
18
|
Kitamura R, Toyoshima T, Tanaka H, Kawano
S, Kiyosue T, Matsubara R, Goto Y, Hirano M, Oobu K and Nakamura S:
Association of cytokeratin 17 expression with differentiation in
oral squamous cell carcinoma. J Cancer Res Clin Oncol.
138:1299–1310. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Toyoshima T, Vairaktaris E, Nkenke E,
Schlegel KA, Neukam FW and Ries J: Cytokeratin 17 mRNA expression
has potential for diagnostic marker of oral squamous cell
carcinoma. J Cancer Res Clin Oncol. 134:515–521. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cohen-Kerem R, Madah W, Sabo E, Rahat MA,
Greenberg E and Elmalah I: Cytokeratin-17 as a potential marker for
squamous cell carcinoma of the larynx. Ann Otol Rhinol Laryngol.
113:821–827. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
van de Rijn M, Perou CM, Tibshirani R,
Haas P, Kallioniemi O, Kononen J, Torhorst J, Sauter G, Zuber M,
Köchli OR, et al: Expression of cytokeratins 17 and 5 identifies a
group of breast carcinomas with poor clinical outcome. Am J Pathol.
161:1991–1996. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ikeda K, Tate G, Suzuki T and Mitsuya T:
Coordinate expression of cytokeratin 8 and cytokeratin 17
immunohistochemical staining in cervical intraepithelial neoplasia
and cervical squamous cell carcinoma: An immunohistochemical
analysis and review of the literature. Gynecol Oncol. 108:598–602.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhong LP, Chen WT, Zhang CP and Zhang ZY:
Increased CK19 expression correlated with pathologic
differentiation grade and prognosis in oral squamous cell carcinoma
patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
104:377–384. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Katsumata K, Sumi T, Mori Y, Hisada M,
Tsuchida A and Aoki T: Detection and evaluation of epithelial cells
in the blood of colon cancer patients using RT-PCR. Int J Clin
Oncol. 11:385–389. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chausovsky G, Luchansky M, Figer A,
Shapira J, Gottfried M, Novis B, Bogelman G, Zemer R, Zimlichman S
and Klein A: Expression of cytokeratin 20 in the blood of patients
with disseminated carcinoma of the pancreas, colon, stomach, and
lung. Cancer. 86:2398–2405. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kawamata H, Uchida D, Nakashiro K, Hino S,
Omotehara F, Yoshida H and Sato M: Haematogenous cytokeratin 20
mRNA as a predictive marker for recurrence in oral cancer patients.
Br J Cancer. 80:448–452. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Toyoshima T, Vairaktaris E, Nkenke E,
Schlegel KA, Neukam FW and Ries J: Hematogenous cytokeratin 20 mRNA
detection has prognostic impact in oral squamous cell carcinoma:
Preliminary results. Anticancer Res. 29:291–297. 2009.PubMed/NCBI
|
|
28
|
Imai Y, Yamagishi H, Fukuda K, Okamura T,
Ono Y, Ban S, Inoue T and Ueda Y: Expression of cytokeratin 20
indicates invasive histological phenotype in poorly differentiated
colorectal adenocarcinoma. Anticancer Res. 34:159–167.
2014.PubMed/NCBI
|
|
29
|
Wahi PN, Cohen B, Luthra UK and Torloni H:
Histological considerationHistological Typing of Oral and
Oropharyngeal Tumors. World Health Organization; Geneva: pp. 15–19.
1977
|
|
30
|
Gale N, Pilch BZ, Sindramsky D, et al:
Epithelium precursor lesionsWorld Health Organization
Classification of Tumors. Pathology and Genetics of Head and Neck
Tumors. Barnes L, Eveson J, Reichart P and Sidransky D: IARC Press;
Lyon: pp. 177–e179. 2005
|
|
31
|
Sobin LH, Sobin LH Witte and Wittekind CH:
TNM Classification of Malignant Tumors. Wiley-Liss, Inc.; New York,
NY: 2002
|
|
32
|
Yamamoto E, Miyakawa A and Kohama G: Mode
of invasion and lymph node metastasis in squamous cell carcinoma of
the oral cavity. Head Neck Surg. 6:938–947. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nagler RM, Barak M, Peled M, Ben-Aryeh H,
Filatov M and Laufer D: Early diagnosis and treatment monitoring
roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell
carcinoma. Cancer. 85:1018–1025. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hartkopf AD, Taran FA, Wallwiener M, Hahn
M, Becker S, Solomayer EF, Brucker SY, Fehm TN and Wallwiener D:
Prognostic relevance of disseminated tumour cells from the bone
marrow of early stage breast cancer patients-results from a large
single-centre analysis. Eur J Cancer. 50:2550–2559. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang F, Li YC, Liu LP, Zhang HM and Tong
S: Circulating tumor cells and tumor stem cells detection in the
peripheral blood mononuclear cells of breast cancer. J Clin Lab
Anal. 30:616–622. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hamakawa H, Bao Y, Takarada M, Fukuzumi M
and Tanioka H: Cytokeratin expression in squamous cell carcinoma of
the lung and oral cavity: An immunohistochemical study with
possible clinical relevance. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod. 85:438–443. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Callet N, Cohen-Solal Le Nir CC, Berthelot
E and Pichon MF: Cancer of the uterine cervix: Sensitivity and
specificity of serum Cyfra 21.1 determinations. Eur J Gynaecol
Oncol. 19:50–56. 1998.PubMed/NCBI
|
|
39
|
Smith B, Selby P, Southgate J, Pittman K,
Bradley C and Blair GE: Detection of melanoma cells in peripheral
blood by means of reverse transcriptase and polymerase chain
reaction. Lancet. 338:1227–1229. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gläser R, Rass K, Seiter S, Hauschild A,
Christophers E and Tilgen W: Detection of circulating melanoma
cells by specific amplification of tyrosinase complementary DNA is
not a reliable tumor marker in melanoma patients: A clinical
two-center study. J Clin Oncol. 15:2818–2825. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jung R, Krüger W, Hosch S, Holweg M,
Kröger N, Gutensohn K, Wagener C, Neumaier M and Zander AR:
Specificity of reverse transcriptase polymerase chain reaction
assays designed for the detection of circulating cancer cells is
influenced by cytokines in vivo and in vitro. Br J Cancer.
78:1194–1198. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yeh KH, Chen YC, Yeh SH, Chen CP, Lin JT
and Cheng AL: Detection of circulating cancer cells by nested
reverse transcription-polymerase chain reaction of cytokeratin-19
(K19)-possible clinical significance in advanced gastric cancer.
Anticancer Res. 18:1283–1286. 1998.PubMed/NCBI
|
|
43
|
Corthay A: Does the immune system
naturally protect against cancer? Front Immunol. 5:1972014.
View Article : Google Scholar : PubMed/NCBI
|
